CIB NYSE Week ended 24 Jul 2026

Weekly Investor Report

Grupo Cibest S.A. · Financial Services · Banks - Regional

Open interactive chart View report data Download investor PDF
Latest close 86.01 USD
7.0% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 18.2% above the Trend Line and sits at 95.5% of its 52-week range. The latest completed week returned 7.0%, after a 10.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 44/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal; earnings are due in 8d.

Setup score 68 out of 100
Latest Close 86.01 USD 24 Jul 2026
1W Return 7.0% latest completed week
4W Return 10.3% short-term follow-through
12W Return 30.4% quarterly tape
Trend Breadth 92.3% 48 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 7-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 12 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.0% Latest completed week; four-week move 10.3%. Indicator stack 75/58 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.21% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bearish 44/100 conviction; expected move 9.2%. News sentiment 52/100 27 relevant articles in the latest sentiment read. Event risk 8d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 18.2% above the Trend Line and sits at 95.5% of its 52-week range. The latest completed week returned 7.0%, after a 10.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4912-week average 0.45

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.49Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1212 reversal markers

No recent accumulation markers. 12 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 10.3% over four weeks, 30.4% over 12 weeks, and 98.3% over one year. The current trend has remained active for 7 consecutive weeks.

Performance by holding period

1W7.0%
4W10.3%
12W30.4%
26W6.5%
52W98.3%
Active trend streak7 weeks
Active weeks in one year48
Trend breadth92.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.53Latest activity-pressure read.
Pressure change-17.5%Four-week change in activity pressure.
Leadership22.65Latest relative-leadership reading.
RS change38.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength25/100Blend of value, momentum, and quality. Underlying universe rank 76; rank 1 is best.
Value39/100Relative valuation strength. Underlying universe rank 62; rank 1 is best.
Quality37/100Profitability and accounting quality. Underlying universe rank 64; rank 1 is best.
Momentum39/100Medium-term price momentum. Underlying universe rank 62; rank 1 is best.
Growth39/100Revenue and earnings growth. Underlying universe rank 62; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
59.3%
Gross profit retained from each unit of revenue.
Operating margin
22.2%
Operating profit retained from revenue.
Free-cash-flow margin
34.3%
Free cash flow generated from revenue.
Return on invested capital
20.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.4%
Latest one-year revenue growth.
EPS growth
10.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
3.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.9%
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

CIB shows bearish options pressure with a 44/100 conviction score, put-call volume ratio of 2.05, expected move of 9.2%, and Sharemaestro trend signal active.

Conviction44/100
Expected move9.2%
Put/call volume2.05
Pressure-27
Speculation32
Volatility65
Trend agreement73
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 27 relevant articles.

5 positive · 20 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings8dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move9.2%Nearest-chain priced movement where available.
52-week drawdown-2.3%Distance below the 52-week high.
13-week volatility5.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+13.1%Week of 12 Jun.
Worst week-14.7%Week of 27 Feb.
Latest week+7.0%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks0
Modest losses9
Sharp losses3
Recent vol5.2%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape65/100

Trend, activity pressure, participation, and risk combine to a 65/100 tape read.

 Indicator analysis49/100

Latest 12-week confirmation: trend 8/12, activity pressure 6/12, relative leadership 8/12.

Activity pressure 0.49; 12 reversal markers Next-Week ExpectancyPositive 57.21%

Next-week expectancy is positive with a 57.21% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors33/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options49/100

CIB shows bearish options pressure with a 44/100 conviction score, put-call volume ratio of 2.05, expected move of 9.2%, and Sharemaestro trend signal active.

Bearish · Put-side pressure · Expected move 9.2% Sentiment52/100

Weighted news tone is neutral across 27 relevant articles.

Goldman Sachs upgrades Grupo Cibest stock rating on profitability outlook Insiders50/100

No recent insider transaction evidence is stored.

 Earnings8d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.

 Research flow5 items

2 recent research articles and 3 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202686.01 USD7.0%72.76 USD41.26 USD0.5322.651.4MOn
17 Jul 202680.41 USD-3.1%72.03 USD40.85 USD0.5715.101.2MOn
10 Jul 202682.95 USD4.8%71.41 USD40.48 USD0.6717.76936.4KOn
3 Jul 202679.15 USD1.5%70.74 USD40.09 USD0.7114.831.1MOn
26 Jun 202677.99 USD-2.7%70.15 USD39.71 USD0.6416.392.9MOn
19 Jun 202680.13 USD1.6%69.61 USD39.33 USD0.1717.591.8MOn
12 Jun 202678.90 USD13.1%68.93 USD38.94 USD-0.3117.732.4MOn
5 Jun 202669.74 USD3.3%68.36 USD38.57 USD-0.785.442.9MOff
29 May 202667.48 USD4.1%68.11 USD38.25 USD-1.11-0.032.0MOff
22 May 202664.82 USD4.3%67.76 USD37.94 USD-1.13-2.181.5MOff
15 May 202662.14 USD-3.2%67.44 USD37.64 USD-1.08-5.081.5MOff
8 May 202664.22 USD-2.6%67.24 USD37.35 USD-0.97-1.391.4MOn
1 May 202665.96 USD-7.8%66.82 USD37.05 USD-0.834.002.1MOn
24 Apr 202671.51 USD-3.2%66.33 USD36.75 USD-0.8214.301.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.